Effectiveness of Decision-aid Video on Colorectal Cancer Screening
DAVOCS
1 other identifier
interventional
400
1 country
1
Brief Summary
Colorectal cancer (CRC) is the second most common cancer in Malaysia. Diagnosing CRC at early stage is crucial to reduce their mortality risk. To achieve this aim, CRC screening promotion intervention is deemed necessary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Mar 2021
Shorter than P25 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2020
CompletedFirst Posted
Study publicly available on registry
January 5, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedJanuary 5, 2021
December 1, 2020
6 months
December 22, 2020
December 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with colorectal cancer screening completion
Number of participants with completion of fecal occult blood test or colonoscopy procedures by participants
3 months
Secondary Outcomes (3)
Number of participants with colonoscopy completion among those with positive fecal occult blood test
3 months
Period time from intervention to fecal occult blood test uptake
3 months
Barriers towards the colorectal cancer screening uptake
3 months
Study Arms (2)
Intervention
EXPERIMENTALParticipants will receive decision-aid video
Usual care
NO INTERVENTIONParticipants will receive usual care
Interventions
Decision-aid video will be developed to disseminate knowledge and to raise awareness on colorectal cancer screening
Eligibility Criteria
You may qualify if:
- Malaysian aged 50 - 74 years old
- No previous history or family history of CRC
- Asymptomatic of CRC
- Never participated in CRC screening
You may not qualify if:
- Acute patients
- Patients on aspirin, warfarin or any blood-thinning agent
- Illiterate or having a significant vision or hearing impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The National University of Malaysia
Cheras, Kuala Lumpur, 56000, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Azmawati Mohammed Nawi
The National University of Malaysia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Investigators will designate participants to which arm using random sampling. Participants and care providers are masked to which arm they receive.
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Public Health Specialist & Medical Lecturer
Study Record Dates
First Submitted
December 22, 2020
First Posted
January 5, 2021
Study Start
March 1, 2021
Primary Completion
September 1, 2021
Study Completion
March 1, 2022
Last Updated
January 5, 2021
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share
Only three principal investigators will have access to participants' data